Canaan X L.P. Iterum Therapeutics PLC (ITRM) insider trading activity

ITRM Quotes by TradingView

Canaan X L.P. is Director of Iterum Therapeutics plc. Currently has a direct ownership of 1.73 Million shares of ITRM, which is worth approximately $2.25 Million. The most recent transaction as insider was on May 30, 2018, when has been sold 506,656 shares (Ordinary Shares) at a price of $13.0 per share, resulting in proceeds of $6,586,528. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.73M
0% 3M change
0% 12M change
Total Value Held $2.25 Million

CANAAN X L.P. Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 30 2018
BUY
Open market or private purchase
$6,586,528 $13.0 p/Share
506,656 Added 22.62%
1,733,170 Ordinary Shares
May 30 2018
BUY
Conversion of derivative security
-
1,226,514 Added 50.0%
1,226,514 Ordinary Shares

Also insider at

IDYA
IDEAYA Biosciences, Inc. Healthcare
> 10% Shareholder
PTGX
Protagonist Therapeutics, Inc Healthcare
> 10% Shareholder
ASTR
Astra Space, Inc. Industrials
> 10% Shareholder
NXTC
NextCure, Inc. Healthcare
> 10% Shareholder
CXL

Canaan X L.P.

Director
Westport, CT

Track Institutional and Insider Activities on ITRM

Follow Iterum Therapeutics plc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ITRM shares.

Notify only if

Insider Trading

Get notified when an Iterum Therapeutics PLC insider buys or sells ITRM shares.

Notify only if

News

Receive news related to Iterum Therapeutics plc

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ITRM